Yingchun Liang

No. 12 WuLuMuQi Middle Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Identification of a novel ferroptosis-inducing micropeptide in bladder cancer.

Identification of a novel ferroptosis-inducing micropeptide in bladder cancer.

Journal: Cancer letters

Published: August 25, 2023

Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment.

Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment.

Journal: Cell death & disease

Published: April 17, 2023

Repair of the Urethral Mucosa Defect Model Using Adipose-Derived Stem Cell Sheets and Monitoring the Fate of Indocyanine Green-Labeled Sheets by Near Infrared-II.

Repair of the Urethral Mucosa Defect Model Using Adipose-Derived Stem Cell Sheets and Monitoring the Fate of Indocyanine Green-Labeled Sheets by Near Infrared-II.

Journal: ACS biomaterials science & engineering

Published: October 06, 2022

Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study.

Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study.

Journal: Frontiers in nutrition

Published: August 01, 2022

m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer.

m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer.

Journal: Cancers

Published: July 27, 2022

The potential mechanism of Longsheyangquan Decoction on the treatment of bladder cancer: Systemic network pharmacology and molecular docking.

The potential mechanism of Longsheyangquan Decoction on the treatment of bladder cancer: Systemic network pharmacology and molecular docking.

Journal: Frontiers in pharmacology

Published: June 10, 2022

Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer.

Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer.

Journal: Frontiers in immunology

Published: April 03, 2022

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer.

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer.

Journal: Frontiers in cell and developmental biology

Published: August 18, 2021

Transcriptome subtyping of metastatic Castration Resistance Prostate Cancer (mCRPC) for the precision therapeutics: an in silico analysis.

Transcriptome subtyping of metastatic Castration Resistance Prostate Cancer (mCRPC) for the precision therapeutics: an in silico analysis.

Journal: Prostate cancer and prostatic diseases

Published: August 03, 2021

Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer.

Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer.

Journal: Cancer cell international

Published: July 02, 2021

Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer.

Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer.

Journal: Frontiers in immunology

Published: June 09, 2021

A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.

A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.

Journal: BMC cancer

Published: December 28, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026